Whistle-blower Ven-A-Care wins in Texas case against drug company
February 2, 2011
Los Angeles Times
By Andrew Zajac
The tiny south Florida pharmacy that built a profitable business blowing the whistle on drug companies that cheat the government has won a signal victory.
A Texas jury on Tuesday ordered two subsidiaries of Icelandic pharmaceuticals company Actavis to pay $170 million for overcharging the Texas Medicaid program. That means the whistle-blower — Ven-A-Care of the Florida Keys Inc. — is in line to receive millions in reward money for acting as the public's watchdog. Read more
